Cargando…
Photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms
Although the whole world is currently observing the global battle against COVID-19, it should not be underestimated that in the next 30 years, approximately 10 million people per year could be exposed to infections caused by multi-drug resistant bacteria. As new antibiotics come under pressure from...
Autores principales: | Pucelik, Barbara, Dąbrowski, Janusz M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787646/ https://www.ncbi.nlm.nih.gov/pubmed/35095189 http://dx.doi.org/10.1016/bs.adioch.2021.12.003 |
Ejemplares similares
-
Photodynamic Inactivation of Bacteria with Porphyrin Derivatives: Effect of Charge, Lipophilicity, ROS Generation, and Cellular Uptake on Their Biological Activity In Vitro
por: Sułek, Adam, et al.
Publicado: (2020) -
Photodynamic Therapy in the Inactivation of Microorganisms
por: Almeida, Adelaide
Publicado: (2020) -
New Trends in Photodynamic Inactivation (PDI) Combating Biofilms in the Food Industry—A Review
por: Wang, Dan, et al.
Publicado: (2021) -
The application of photodynamic inactivation to microorganisms in food
por: Zhu, Shengyu, et al.
Publicado: (2021) -
Effects of Photodynamic Therapy with Redaporfin on Tumor Oxygenation and Blood Flow in a Lung Cancer Mouse Model
por: Karwicka, Malwina, et al.
Publicado: (2019)